(Q44418473)

English

Influence of antithymocyte globulin dose on outcome in cytomegalovirus‐seropositive recipients of partially T cell‐depleted stem cell grafts from matched‐unrelated donors

scientific article published on May 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 December 2017

Influence of antithymocyte globulin dose on outcome in cytomegalovirus-seropositive recipients of partially T cell-depleted stem cell grafts from matched-unrelated donors (English)

1 reference

Europe PubMed Central

2 December 2017

Influence of antithymocyte globulin dose on outcome in cytomegalovirus‐seropositive recipients of partially T cell‐depleted stem cell grafts from matched‐unrelated donors (English)

1 reference

10.1046/J.1365-2141.2003.04294.X

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04294.X

28 December 2023

Cytomegalovirus

0 references

author name string

Ellen Meijer

1

1 reference

Europe PubMed Central

2 December 2017

Adriaan W. Dekker

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12716371

28 December 2023

Leo F. Verdonck

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12716371

28 December 2023

language of work or name

0 references

publication date

1 May 2003

1 reference

Europe PubMed Central

2 December 2017

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2141.2003.04294.x

1 reference

10.1046/J.1365-2141.2003.04294.X

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04294.X

28 December 2023

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2141.2003.04294.x

1 reference

10.1046/J.1365-2141.2003.04294.X

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04294.X

28 December 2023

British Journal of Haematology

1 reference

Europe PubMed Central

2 December 2017

121

1 reference

Europe PubMed Central

2 December 2017

3

1 reference

Europe PubMed Central

2 December 2017

473-476

1 reference

Europe PubMed Central

2 December 2017

Quantification of human cytomegalovirus DNA in bone marrow transplant recipients by real-time PCR.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04294.X

21 January 2018

Influence of cytomegalovirus seropositivity on outcome after T cell-depleted bone marrow transplantation: contrasting results between recipients of grafts from related and unrelated donors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04294.X

21 January 2018

High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04294.X

21 January 2018

Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04294.X

21 January 2018

Extended routine polymerase chain reaction surveillance and pre-emptive antiviral therapy for cytomegalovirus after allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04294.X

21 January 2018

Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft-versus-host disease prophylaxis

1

1 reference

10.1046/J.1365-2141.2003.04294.X

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04294.X

28 December 2023

Effect of cytomegalovirus infection on 1-year mortality rates among recipients of allogeneic bone marrow transplants

3

1 reference

10.1046/J.1365-2141.2003.04294.X

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04294.X

28 December 2023

Patient cytomegalovirus seropositivity with or without reactivation is the most important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T-cell depletion

4

1 reference

10.1046/J.1365-2141.2003.04294.X

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04294.X

28 December 2023

Real-time automated PCR for early diagnosis and monitoring of cytomegalovirus infection after bone marrow transplantation

5

1 reference

10.1046/J.1365-2141.2003.04294.X

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04294.X

28 December 2023

Risk factors for cytomegalovirus infection after human marrow transplantation

7

1 reference

10.1046/J.1365-2141.2003.04294.X

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04294.X

28 December 2023

Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells

8

1 reference

10.1046/J.1365-2141.2003.04294.X

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04294.X

28 December 2023

Identifiers

10.1046/J.1365-2141.2003.04294.X

1 reference

Europe PubMed Central

2 December 2017

1 reference

Europe PubMed Central

2 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44418473&oldid=2040101144"